Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.


GenEp Raises $1.45 Million Seed Financing

October 26, 2021
GenEp, Inc., a biotechnology company developing therapies that address unmet needs in patients with epilepsy, announced today the closing of a $1.45 million seed financing. The financing was co-led... Learn More

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

October 18, 2021
HistoSonics, the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today that the U.S. Food and Drug Administration (FDA) has granted... Learn More

Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF)

July 28, 2021
- Angelini Pharma will invest US$35 million and be the sole investor in this innovative fund - ALBF will invest in early-stage companies developing pharmaceuticals to treat central nervous system... Learn More

Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies

July 26, 2021
Oversubscribed Lumira Ventures IV to continue successful focus backing biotechnology and medtech companies in Canada and U.S. Companion strategic fund formed in partnership with international... Learn More

Team Lumira

Our investment team of 12 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.



Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.

  • "Lumira's philanthropic vision of leveraging research, resources and knowledge to improve the lives of patients will strengthen St. Michael's ability to accelerate the pace."

    Dr. Arthur Slutsky | Vice-President
    Vice-President of Research at St. Michael's Hospital
  • "Lumira's model provides a new pathway for philanthropy to partner with investors in advancing healthcare innovation."

    Barbara Grantham | President & Ceo
    VGH & UBC Hospital Foundation
  • “This distinctive approach to supporting innovation is very creative, very much needed and very much appreciated by Princess Margaret and University Health Network.”

    Paul Alofs | President & Ceo
    Princess Margaret Cancer Foundation

Contact Us

Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.



141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5



Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7



1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3



303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208